261 results on '"Dekkers, Ilona A."'
Search Results
2. Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
3. Contrast media for hysterosalpingography: systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital Radiology
4. Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?
5. Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines
6. Iodine-based contrast media in contrast-enhanced mammography and dedicated breast computed tomography: is it necessary to assess renal function in all outpatients to prevent contrast-induced acute kidney injury?
7. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS)
8. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward
9. Metabolic Imaging: Measuring Fat in the Kidney
10. Correction: Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward
11. Obesity and the brain
12. List of contributors
13. Obesity in relation to cardiorenal function
14. Report on the ISMRM-ESMRMB 2022 hot topic debate on the future of gadolinium as a contrast agent
15. Consensus-based technical recommendations for clinical translation of renal BOLD MRI.
16. Consensus-based technical recommendations for clinical translation of renal diffusion-weighted MRI
17. Correction to: Consensus-based technical recommendations for clinical translation of renal diffusion-weighted MRI
18. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1—intravenous administration
19. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2—intra-arterial administration
20. Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines
21. Confirmatory factor analysis including MRI-derived adipose tissues quantification improves associations of metabolic dysregulation to diastolic dysfunction
22. Estimated pulse wave velocity (ePWV) as a potential gatekeeper for MRI-assessed PWV: a linear and deep neural network based approach in 2254 participants of the Netherlands Epidemiology of Obesity study
23. MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 Diabetes.
24. Leisure time physical activity is associated with improved diastolic heart function and is partly mediated by unsupervised quantified metabolic health
25. The Effect of Glycemic Control on Renal Triglyceride Content Assessed by Proton Spectroscopy in Patients With Type 2 Diabetes Mellitus: A Single-Center Parallel-Group Trial
26. Noninvasive Advanced Cardiovascular Magnetic Resonance–Derived Fontan Hemodynamics Are Associated With Reduced Kidney Function But Not Albuminuria
27. Cardiovascular Magnetic Resonance-derived Fontan Hemodynamics Are Associated with Reduced Kidney Function but Not Albuminuria in Single Ventricle Patients
28. Renal sinus fat volume in type 2 diabetes mellitus is associated with glycated hemoglobin and metabolic risk factors
29. Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction
30. Associations between left ventricular function, vascular function and measures of cerebral small vessel disease: a cross-sectional magnetic resonance imaging study of the UK Biobank
31. Dynamic rubidium‐82 PET/CT as a novel tool for quantifying hemodynamic differences in renal blood flow using a one‐tissue compartment model.
32. The Separate Contributions of Visceral Fat and Liver Fat to Chronic Kidney Disease-Related Renal Outcomes
33. MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 Diabetes
34. Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
35. Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines
36. Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population
37. Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI
38. Technical recommendations for clinical translation of renal MRI: a consensus project of the Cooperation in Science and Technology Action PARENCHIMA
39. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
40. Associations between normal range albuminuria, renal function and cardiovascular function in a population-based imaging study
41. Kiosk 3R-TA-06 - Cardiovascular Magnetic Resonance-derived Fontan Hemodynamics Are Associated with Reduced Kidney Function but Not Albuminuria in Single Ventricle Patients
42. Artificial Intelligence to Reduce or Eliminate the Need for Gadolinium-Based Contrast Agents in Brain and Cardiac MRI
43. Editorial for “MRI Assessment of Renal Lipid Deposition and Abnormal Oxygen Metabolism of Type 2 diabetes Mellitus Based on mDixon‐Quant”
44. Phenotyping diabetic cardiomyopathy in Europeans and South Asians
45. Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
46. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
47. Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency
48. Effect of glucose regulation on renal parenchyma and sinus fat volume in patients with type 2 diabetes
49. Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
50. Incidental Findings on Brain Imaging in the General Pediatric Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.